Latest AI and machine learning research in chemotherapy for healthcare professionals.
Local recurrences (LR) can occur within residual breast tissue, chest wall, skin, or newly formed sc...
INTRODUCTION: For patients with breast cancer, the amplification of Human Epidermal Growth Factor 2 ...
PURPOSE: To investigate the feasibility of characterizing tumor heterogeneity in breast cancer ultra...
BACKGROUND: Adjuvant radiotherapy is essential for reducing local recurrence and improving survival ...
PURPOSE: Build machine learning (ML) models able to predict pathological complete response (pCR) aft...
Esophageal squamous cell carcinoma (ESCC), a predominant subtype of esophageal cancer, typically pre...
An efficient novel approach is introduced to predict the effectiveness of chemotherapy treatment in ...
SIGNIFICANCE: Maximal safe resection of brain tumors can be performed by neurosurgeons through the u...
Neoadjuvant chemotherapy (NAC) is a systemic and systematic chemotherapy regimen for breast cancer p...
BACKGROUND: Hematologic changes after splenectomy and hyperthermic intraperitoneal chemotherapy (HIP...
Human organic cation transporter 2 (hOCT2/SLC22A2) is a key drug transporter that facilitates the tr...
PURPOSE: This systematic review examines the utility of deep learning algorithms in predicting patho...
New methodologies have been evaluated for validating analytical characterization with artificial neu...
OBJECTIVE: Non-puerperal mastitis (NPM) is an inflammatory breast disease affecting women during non...
Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia predominantly affecti...
BACKGROUND: Alopecia areata (AA) is a common non-scarring hair loss disorder associated with autoimm...
BACKGROUND: Programmed cell death plays an important role in neuronal injury and death after ischemi...
BACKGROUND: This study explores the clinical value of a machine learning (ML) model based on ultraso...
RATIONALE AND OBJECTIVES: The precise prediction of response to neoadjuvant chemoradiotherapy is cru...
BACKGROUND: Neoadjuvant chemotherapy is standard for advanced esophageal squamous cell carcinoma, th...
BACKGROUND: Thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) exhibit a notably aggres...